or Try an Advanced Search...

    Growth Hormone Therapy Stocks List

    Symbol Grade Name % Change
    ASND D Ascendis Pharma A/S -2.76
    NVO D Novo Nordisk A/S -0.78
    LUMO C Lumos Pharma, Inc. -2.63
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension

    Related ETFs - A few ETFs which own one or more of the above listed Growth Hormone Therapy stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.21
    MEDI C Harbor Health Care ETF 16.22
    PPH C Market Vectors Pharmaceutical ETF 9.83
    IGTR B Innovator Gradient Tactical Rotation Strategy ETF 8.1
    PJIO D PGIM Jennison International Opportunities ETF 7.68
    View all Growth Hormone Therapy ETFs...
    Compare ETFs
    Compare IGTR to PJIO Compare PPH to IGTR Compare PPH to PJIO

        Growth Hormone Therapy Stocks Recent News

        Date Stock Title
        May 3 NVO Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 NVO Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
        May 3 NVO Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 NVO The FTC Cracks Down On Novo Nordisk's Ozempic
        May 3 NVO Weight-loss drug competition heats up. Is Wegovy in trouble?
        May 3 NVO Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
        May 3 NVO Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
        May 3 NVO FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
        May 3 NVO Catalent, Novo Nordisk receive FTC request for more information
        May 3 NVO US FTC seeks more information on Novo Nordisk parent-Catalent deal
        May 3 NVO UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
        May 3 NVO Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected
        May 3 NVO How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
        May 3 NVO This Is a Huge Sigh of Relief for Novo Nordisk Investors
        May 3 NVO Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
        May 3 NVO Novo slides as Amgen fuels obesity drug competition fears
        May 3 NVO Here’s How Novo Holdings’ Catalent (CTLT) Acquisition Affects Laughing Water Capital
        May 2 NVO Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 ASND Ascendis Pharma reports Q1 results
        May 2 NVO Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
        Related Industries: Biotechnology
        Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension
        Growth Hormone Therapy

        Growth hormone therapy is a medical treatment that involves the use of growth hormones to treat a variety of conditions, including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and other conditions. Growth hormone therapy is typically administered through injections, and it helps to stimulate the body’s natural production of growth hormones. This can help to improve physical growth, muscle mass, bone density, and overall health.

        Browse All Tags